https://www.selleckchem.com/pr....oducts/almorexant-hc
05; 95% CI 1.03-1.08), also evident in people with CHD (HR 1.08; 95% CI 1.01-1.14). Point estimates for hazard ratios across all BMI values in participants with T2DM and cancer were consistent with overall positive linear effects but confidence intervals included the null. These data support the idea that population efforts to promote intentional weight loss towards the normal BMI range would reduce, not enhance, mortality risk in the general population including, importantly, individuals with CHD. These data support the idea tha
Like
Comment
Share
